0.5577
price down icon5.73%   -0.0339
after-market Handel nachbörslich: .56 0.0023 +0.41%
loading

Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten

pulisher
Dec 09, 2025

Century Therapeutics Appoints Dr. Han Lee and Dr. Martin Murphy To Board - citybiz

Dec 09, 2025
pulisher
Dec 09, 2025

Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors - Yahoo Finance

Dec 09, 2025
pulisher
Dec 09, 2025

Century Therapeutics appoints two new board members - Investing.com

Dec 09, 2025
pulisher
Dec 09, 2025

Century Therapeutics appoints two new board members By Investing.com - Investing.com Nigeria

Dec 09, 2025
pulisher
Dec 09, 2025

Century Therapeutics Appoints Accomplished Biotechnology - GlobeNewswire

Dec 09, 2025
pulisher
Dec 05, 2025

Century Therapeutics Announces Strategic Pipeline Shift and 2024 Financial Results - MSN

Dec 05, 2025
pulisher
Dec 03, 2025

Will Century Therapeutics Inc. stock outperform international peersMarket Growth Summary & AI Driven Stock Price Forecasts - Newser

Dec 03, 2025
pulisher
Nov 28, 2025

What analysts say about APA Corporation stockMarket Sentiment Report & Enter Your Email to Get Stock Alerts - earlytimes.in

Nov 28, 2025
pulisher
Nov 25, 2025

Century Therapeutics 'moving with urgency' to develop drug for Type 1 diabetes - The Business Journals

Nov 25, 2025
pulisher
Nov 25, 2025

Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference - Investing News Network

Nov 25, 2025
pulisher
Nov 25, 2025

There is no way Century Therapeutics Inc (IPSC) can keep these numbers up - Setenews

Nov 25, 2025
pulisher
Nov 24, 2025

[Form 4] Century Therapeutics, Inc. Insider Trading Activity - Stock Titan

Nov 24, 2025
pulisher
Nov 21, 2025

Century Therapeutics Debuts Immune-Evasive Cell Therapy Aiming to Transform Type 1 Diabetes - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

IPSC 2026 special meeting to vote on Nasdaq-driven reverse split - Stock Titan

Nov 21, 2025
pulisher
Nov 20, 2025

Century Therapeutics Unveils iPSC Beta Islet Program as Cash Runway Extends Into 2027 - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Century Therapeutics Executive Acquires 35,000 Shares - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

Chmn Pfeiffenberger Buys 35,000 ($17.3K) Of Century Therapeutics Inc [IPSC] - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

Officer Cowan Files To Sell 5,462 Of Century Therapeutics Inc [IPSC] - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

Research Analysts Set Expectations for IPSC FY2025 Earnings - Defense World

Nov 20, 2025
pulisher
Nov 20, 2025

Century Therapeutics Inc. stock momentum explainedMarket Performance Recap & Weekly Stock Performance Updates - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

What machine learning models say about Century Therapeutics Inc.2025 Fundamental Recap & Daily Technical Forecast Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Century Therapeutics Executive Sells Shares to Cover Tax Obligations - TradingView

Nov 19, 2025
pulisher
Nov 19, 2025

Real time pattern detection on Century Therapeutics Inc. stockIPO Watch & Safe Capital Growth Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Leerink Partners Reaffirms “Market Perform” Rating for Century Therapeutics (NASDAQ:IPSC) - Defense World

Nov 19, 2025
pulisher
Nov 19, 2025

Leerink Partnrs Downgrades Century Therapeutics (NASDAQ:IPSC) to Hold - Defense World

Nov 19, 2025
pulisher
Nov 18, 2025

Take off with Century Therapeutics Inc (IPSC): Get ready for trading - Setenews

Nov 18, 2025
pulisher
Nov 17, 2025

What technical signals suggest for Century Therapeutics Inc. stockCPI Data & Accurate Entry and Exit Point Alerts - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

How Century Therapeutics Inc. stock compares to industry benchmarksMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Century Therapeutics Shares Fall After Leerink Partners Downgrade - MarketScreener

Nov 17, 2025
pulisher
Nov 17, 2025

IPSC Stock Downgraded by Leerink Partners: Price Target Slashed - GuruFocus

Nov 17, 2025
pulisher
Nov 17, 2025

Leerink Partners Downgrades Century Therapeutics to Market Perform From Outperform, Price Target is $7 - MarketScreener

Nov 17, 2025
pulisher
Nov 17, 2025

Century Therapeutics stock downgraded by Leerink Partners on lack of catalysts - Investing.com Canada

Nov 17, 2025
pulisher
Nov 17, 2025

Leerink Partners Downgrades Century Therapeutics to Market Perform From Outperform - marketscreener.com

Nov 17, 2025
pulisher
Nov 16, 2025

What Fibonacci levels say about Century Therapeutics Inc. reboundRisk Management & Free Technical Confirmation Trade Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Analyzing drawdowns of Century Therapeutics Inc. with statistical toolsQuarterly Market Summary & AI Powered Market Entry Strategies - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Century Therapeutics Inc. stock trend outlook and recovery pathWeekly Trade Recap & High Accuracy Investment Entry Signals - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Published on: 2025-11-15 03:30:02 - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Can volume confirm reversal in Century Therapeutics Inc.2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Century Therapeutics Shrinks Costs But Net Loss Widens - Finimize

Nov 14, 2025
pulisher
Nov 14, 2025

Century Therapeutics unveils β islet program for type 1 diabetes - BioWorld MedTech

Nov 14, 2025
pulisher
Nov 14, 2025

Century Therapeutics Reports Positive Q3 2025 Earnings - TipRanks

Nov 14, 2025
pulisher
Nov 13, 2025

Century Therapeutics Inc. stock trendline breakdownPortfolio Growth Summary & Daily Technical Stock Forecast Reports - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Century Therapeutics unveils T1D therapy program with immune evasion tech By Investing.com - Investing.com Nigeria

Nov 13, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):